ArticleHeliyon2025
The stage- and subgroup-specific impact of non-HLA polymorphisms on preclinical type 1 diabetes progression.
Julie Vandewalle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it